Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
RUA Life Sciences (GB:RUA)
LSE:RUA
Holding GB:RUA?
Track your performance easily
RUA Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range8.50p - 58.75p
Previous Close12.5p
Volume701.63K
Average Volume (3M)260.48K
Market Cap
£7.76M
Enterprise Value6.75M
Total Cash (Recent Filing)£1.48M
Total Debt (Recent Filing)£475.00K
Price to Earnings (P/E)―
Beta-0.24
Next Earnings
Dec 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding62,060,272
10 Day Avg. Volume291,236
30 Day Avg. Volume260,481
Standard Deviation0.25
R-Squared0.02
Alpha0.00208
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)3.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RUA Life Sciences News
PremiumCompany Announcements
RUA Life Sciences Acquires Medical Device Firm Abiss
PremiumCompany Announcements
RUA Life Sciences AGM Concludes with Full Approval
PremiumCompany Announcements
RUA Life Sciences Sees Strong Financial Start
PremiumCompany Announcements
RUA Life Sciences Secures Lucrative New Contract
PremiumCompany Announcements
RUA Life Sciences: Growth and Strategic Pivot
PremiumCompany Announcements
RUA Life Sciences Announces Board Revamp and Option GrantsOptions Prices
Currently, No data available
---
Ownership Overview
7.22% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
92.78% Public Companies and
Individual Investors
RUA FAQ
What was RUA Life Sciences’s price range in the past 12 months?
RUA Life Sciences lowest share price was 8.50p and its highest was 58.75p in the past 12 months.
What is RUA Life Sciences’s market cap?
Currently, no data Available
When is RUA Life Sciences’s upcoming earnings report date?
RUA Life Sciences’s upcoming earnings report date is Dec 12, 2024 which is in 83 days.
How were RUA Life Sciences’s earnings last quarter?
RUA Life Sciences released its earnings results on Jul 24, 2024. The company reported -0.007p earnings per share for the quarter, missing the consensus estimate of N/A by -0.007p.
Is RUA Life Sciences overvalued?
According to Wall Street analysts RUA Life Sciences’s price is currently Overvalued.
Does RUA Life Sciences pay dividends?
RUA Life Sciences does not currently pay dividends.
What is RUA Life Sciences’s EPS estimate?
RUA Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RUA Life Sciences have?
RUA Life Sciences has 62,060,272 shares outstanding.
What happened to RUA Life Sciences’s price movement after its last earnings report?
RUA Life Sciences reported an EPS of -0.007p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.273%.
Which hedge fund is a major shareholder of RUA Life Sciences?
Currently, no hedge funds are holding shares in GB:RUA
---
RUA Life Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-28.57%
12-Months-Change
Fundamentals
Return on Equity
-24.27%
Trailing 12-Months
Asset Growth
44.25%
Trailing 12-Months
Company Description
RUA Life Sciences
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's only operating segment; exploiting the value of its IP and know-how. Geographically, it derives most of the revenue from the USA and has a presence in Europe and the Rest of the world. It has developed biostable, implantable polymers, including technology such as Elast-Eon, Elast-Eon Carbonate Silicone, and Elast-Eon Reaction Injection Molding (RIM) technology. Also, the company has developed a range of large bore vascular grafts. The company earns its revenues in the form of royalties and license fees.
---
Technical Analysis
---